TrialAlign

The clinical research industry is entering a new era of performance transparency where data, not legacy relationships, drives site selection.  That was the central theme of the recent SCRS hosted webinar, “Outdated Metrics, Missed Opportunities: Rethinking Site Selection in 2025.” Industry leaders came together to discuss how artificial intelligence, data analytics, and site-sponsor collaboration are … Read more

Site selection in clinical trials is stunted, often driven by past relationships and familiarity. In fact, studies show that in any given multi-site trial, about 70% of participating sites were previously used by the sponsor1. While there are advantages to reusing known sites, like faster contracting, established workflows, and existing relationships, past collaboration doesn’t always … Read more